These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 17338160

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma.
    Parker AS, Burton JH, Curran KM, Wolf-Ringwall A, Thamm DH.
    J Vet Intern Med; 2024; 38(4):2282-2292. PubMed ID: 38961691
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
    Fahey CE, Milner RJ, Barabas K, Lurie D, Kow K, Parfitt S, Lyles S, Clemente M.
    J Am Vet Med Assoc; 2011 Jul 15; 239(2):209-15. PubMed ID: 21756176
    [Abstract] [Full Text] [Related]

  • 5. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD, Ogilvie GK, Mallinckrodt CH, Getzy DM.
    J Am Vet Med Assoc; 1997 Feb 15; 210(4):512-6. PubMed ID: 9040837
    [Abstract] [Full Text] [Related]

  • 6. Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.
    Cawley JR, Wright ZM, Meleo K, Post GS, Clifford CA, Vickery KR, Vail DM, Bergman PJ, Thamm DH.
    J Vet Intern Med; 2020 Mar 15; 34(2):882-889. PubMed ID: 32064697
    [Abstract] [Full Text] [Related]

  • 7. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
    Sauerbrey ML, Mullins MN, Bannink EO, Van Dorp TE, Kaneene JB, Obradovich JE.
    J Am Vet Med Assoc; 2007 Jun 15; 230(12):1866-9. PubMed ID: 17571992
    [Abstract] [Full Text] [Related]

  • 8. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.
    Flory AB, Rassnick KM, Al-Sarraf R, Bailey DB, Balkman CE, Kiselow MA, Autio K.
    J Vet Intern Med; 2008 Jun 15; 22(1):164-71. PubMed ID: 18289305
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT, Mauldin GE, Mauldin GN, Brodsky EM, Post GS.
    Vet Comp Oncol; 2010 Mar 15; 8(1):11-22. PubMed ID: 20230577
    [Abstract] [Full Text] [Related]

  • 10. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma.
    Jeffreys AB, Knapp DW, Carlton WW, Thomas RM, Bonney PL, Degortari A, Lucroy MD.
    J Am Anim Hosp Assoc; 2005 Mar 15; 41(4):221-6. PubMed ID: 15995158
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
    Tanis JB, Mason SL, Maddox TW, Blackwood L, Killick DR, Amores-Fuster I, Harper A, Finotello R.
    Vet Comp Oncol; 2018 Sep 15; 16(3):361-369. PubMed ID: 29380942
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD, Ogilvie GK, Fettman MJ, Walton JA, Richardson K, Powers BE, McNiel EA, Rogers QR.
    J Am Vet Med Assoc; 1999 Feb 01; 214(3):353-6. PubMed ID: 10023395
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma.
    MacEwen EG, Rosenthal RC, Fox LE, Loar AS, Kurzman ID.
    J Vet Intern Med; 1992 Feb 01; 6(4):230-4. PubMed ID: 1522554
    [Abstract] [Full Text] [Related]

  • 14. Asparaginase and MOPP treatment of dogs with lymphoma.
    Brodsky EM, Maudlin GN, Lachowicz JL, Post GS.
    J Vet Intern Med; 2009 Feb 01; 23(3):578-84. PubMed ID: 19645842
    [Abstract] [Full Text] [Related]

  • 15. Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
    Rassnick KM, Bailey DB, Malone EK, Intile JL, Kiselow MA, Flory AB, Barlow LL, Balkman CE, Barnard SM, Waite AH.
    Vet Comp Oncol; 2010 Dec 01; 8(4):243-53. PubMed ID: 21062406
    [Abstract] [Full Text] [Related]

  • 16. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
    Simon D, Nolte I, Eberle N, Abbrederis N, Killich M, Hirschberger J.
    J Vet Intern Med; 2006 Dec 01; 20(4):948-54. PubMed ID: 16955821
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma.
    Rassnick KM, McEntee MC, Erb HN, Burke BP, Balkman CE, Flory AB, Kiselow MA, Autio K, Gieger TL.
    J Vet Intern Med; 2007 Dec 01; 21(6):1364-73. PubMed ID: 18196748
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.